{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T18:48:19Z","timestamp":1772650099815,"version":"3.50.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T00:00:00Z","timestamp":1712966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T00:00:00Z","timestamp":1712966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Chemistry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cyclin-dependent kinase 8 (CDK8) has emerged as a promising target for inhibiting cancer cell function, intensifying efforts towards the development of CDK8 inhibitors as potential cancer therapeutics. Mutations in CDK8, a protein kinase, are also implicated as a primary factor associated with tumor formation. In this study, we identified potential inhibitors through virtual screening for CDK8 and single amino acid mutations in CDK8, namely D173A (Aspartate 173 mutate to Alanine), D189N (Aspartate 189 mutate to Asparagine), T196A (Threonine 196 mutate to Alanine) and T196D (Threonine 196 mutate to Aspartate). Four databases (CHEMBEL, ZINC, MCULE, and MolPort) containing 65,209,131 molecules have been searched to identify new inhibitors for CDK8 and its single mutations. In the first step, structure-based pharmacophore modeling in the Pharmit server was used to select the compounds to know the inhibitors. Then molecules with better predicted drug-like molecule properties were selected. The final filter used to select more effective inhibitors among the previously selected molecules was molecular docking. Finally, 13 hits for CDK8, 11 hits for D173A, 11 hits for D189N, 15 hits for T196A, and 12 hits for T196D were considered potential inhibitors. A majority of the virtual screening hits exhibited satisfactorily predict pharmacokinetic characteristics and toxicity properties.<\/jats:p>","DOI":"10.1186\/s13065-024-01175-6","type":"journal-article","created":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T18:02:13Z","timestamp":1713031333000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Hit discovery of potential CDK8 inhibitors and analysis of amino acid mutations for cancer therapy through computer-aided drug discovery"],"prefix":"10.1186","volume":"18","author":[{"given":"Raziye","family":"Aghahasani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fereshteh","family":"Shiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Kamaladiny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Haddadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somayeh","family":"Pirhadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,13]]},"reference":[{"issue":"3","key":"1175_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"1175_CR2","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1016\/j.bmcl.2016.03.015","volume":"26","author":"J Kaur","year":"2016","unstructured":"Kaur J, Kaur S, Singh P. Rational modification of the lead molecule: enhancement in the anticancer and dihydrofolate reductase inhibitory activity. Bioorg Med Chem Lett. 2016;26(8):1936\u201340.","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"1175_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-018-0804-2","volume":"17","author":"KS Bhullar","year":"2018","unstructured":"Bhullar KS, Lagar\u00f3n NO, McGowan EM, Parmar I, Jha A, Hubbard BP, et al. Kinase-targeted cancer therapies: progress, challenges and future directions. Mol Cancer. 2018;17(1):1\u201320.","journal-title":"Mol Cancer"},{"issue":"2","key":"1175_CR4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.bmcl.2017.11.049","volume":"28","author":"J Kaur","year":"2018","unstructured":"Kaur J, Kaur B, Singh P. Rational modification of semaxanib and sunitinib for developing a tumor growth inhibitor targeting ATP binding site of tyrosine kinase. Bioorg Med Chem Lett. 2018;28(2):129\u201333.","journal-title":"Bioorg Med Chem Lett"},{"issue":"15","key":"1175_CR5","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1242\/dev.091744","volume":"140","author":"S Lim","year":"2013","unstructured":"Lim S, Kaldis P. Cdks, cyclins and CKIs: roles beyond cell cycle regulation. Development. 2013;140(15):3079\u201393.","journal-title":"Development"},{"issue":"2","key":"1175_CR6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jmb.2011.07.020","volume":"412","author":"E Schneider","year":"2011","unstructured":"Schneider E, B\u00f6ttcher J, Blaesse M, Neumann L, Huber R, Maskos K. The structure of CDK8\/CycC implicates specificity in the CDK\/cyclin family and reveals interaction with a deep pocket binder. J Mol Biol. 2011;412(2):251\u201366.","journal-title":"J Mol Biol"},{"issue":"20","key":"1175_CR7","doi-asserted-by":"publisher","first-page":"8081","DOI":"10.1073\/pnas.1305378110","volume":"110","author":"EV Schneider","year":"2013","unstructured":"Schneider EV, B\u00f6ttcher J, Huber R, Maskos K, Neumann L. Structure\u2013kinetic relationship study of CDK8\/CycC specific compounds. Proc Natl Acad Sci. 2013;110(20):8081\u20136.","journal-title":"Proc Natl Acad Sci"},{"issue":"5600","key":"1175_CR8","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1126\/science.1075762","volume":"298","author":"G Manning","year":"2002","unstructured":"Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. The protein kinase complement of the human genome. Science. 2002;298(5600):1912\u201334.","journal-title":"Science"},{"issue":"6","key":"1175_CR9","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.cell.2004.05.018","volume":"117","author":"A Alonso","year":"2004","unstructured":"Alonso A, Sasin J, Bottini N, Friedberg I, Friedberg I, Osterman A, et al. Protein tyrosine phosphatases in the human genome. Cell. 2004;117(6):699\u2013711.","journal-title":"Cell"},{"key":"1175_CR10","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.ejmech.2017.08.071","volume":"142","author":"S Kalra","year":"2017","unstructured":"Kalra S, Joshi G, Munshi A, Kumar R. Structural insights of cyclin dependent kinases: implications in design of selective inhibitors. Eur J Med Chem. 2017;142:424\u201358.","journal-title":"Eur J Med Chem"},{"issue":"9","key":"1175_CR11","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.bbagrm.2013.04.010","volume":"1829","author":"Z Szilagyi","year":"2013","unstructured":"Szilagyi Z, Gustafsson CM. Emerging roles of Cdk8 in cell cycle control. Biochim Biophys Acta (BBA) Gene Regul Mech. 2013;1829(9):916\u201320.","journal-title":"Biochim Biophys Acta (BBA) Gene Regul Mech"},{"issue":"1","key":"1175_CR12","first-page":"1","volume":"6","author":"D Xu","year":"2015","unstructured":"Xu D, Li C-F, Zhang X, Gong Z, Chan C-H, Lee S-W, et al. Skp2\u2013MacroH2A1\u2013CDK8 axis orchestrates G2\/M transition and tumorigenesis. Nat Commun. 2015;6(1):1\u201314.","journal-title":"Nat Commun"},{"issue":"7327","key":"1175_CR13","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/nature09590","volume":"468","author":"A Kapoor","year":"2010","unstructured":"Kapoor A, Goldberg MS, Cumberland LK, Ratnakumar K, Segura MF, Emanuel PO, et al. The histone variant macroH2A suppresses melanoma progression through regulation of CDK8. Nature. 2010;468(7327):1105\u20139.","journal-title":"Nature"},{"issue":"7","key":"1175_CR14","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1158\/1078-0432.CCR-16-0094","volume":"23","author":"J Br\u00e4gelmann","year":"2017","unstructured":"Br\u00e4gelmann J, Kl\u00fcmper N, Offermann A, Von Maessenhausen A, B\u00f6hm D, Deng M, et al. Pan-cancer analysis of the mediator complex transcriptome identifies CDK19 and CDK8 as therapeutic targets in advanced prostate cancer CDK19 as a therapeutic target in advanced prostate cancer. Clin Cancer Res. 2017;23(7):1829\u201340.","journal-title":"Clin Cancer Res"},{"issue":"6800","key":"1175_CR15","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/35024111","volume":"407","author":"S Akoulitchev","year":"2000","unstructured":"Akoulitchev S, Chuikov S, Reinberg D. TFIIH is negatively regulated by cdk8-containing mediator complexes. Nature. 2000;407(6800):102\u20136.","journal-title":"Nature"},{"issue":"7212","key":"1175_CR16","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nature07179","volume":"455","author":"R Firestein","year":"2008","unstructured":"Firestein R, Bass AJ, Kim SY, Dunn IF, Silver SJ, Guney I, et al. CDK8 is a colorectal cancer oncogene that regulates \u03b2-catenin activity. Nature. 2008;455(7212):547\u201351.","journal-title":"Nature"},{"issue":"7132","key":"1175_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nature05610","volume":"446","author":"C Greenman","year":"2007","unstructured":"Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, et al. Patterns of somatic mutation in human cancer genomes. Nature. 2007;446(7132):153\u20138.","journal-title":"Nature"},{"key":"1175_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.compbiolchem.2014.03.003","volume":"51","author":"W Xu","year":"2014","unstructured":"Xu W, Amire-Brahimi B, Xie X-J, Huang L, Ji J-Y. All-atomic molecular dynamic studies of human CDK8: insight into the A-loop, point mutations and binding with its partner CycC. Comput Biol Chem. 2014;51:1\u201311.","journal-title":"Comput Biol Chem"},{"key":"1175_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106552","volume":"187","author":"R Roskoski Jr","year":"2023","unstructured":"Roskoski R Jr. Properties of FDA-approved small molecule protein kinase inhibitors: a 2023 update. Pharmacol Res. 2023;187: 106552.","journal-title":"Pharmacol Res"},{"issue":"19\u201320","key":"1175_CR20","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.drudis.2012.06.018","volume":"17","author":"G-F Hao","year":"2012","unstructured":"Hao G-F, Yang G-F, Zhan C-G. Structure-based methods for predicting target mutation-induced drug resistance and rational drug design to overcome the problem. Drug Discov Today. 2012;17(19\u201320):1121\u20136.","journal-title":"Drug Discov Today"},{"issue":"3","key":"1175_CR21","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.3390\/cancers6031769","volume":"6","author":"G Housman","year":"2014","unstructured":"Housman G, Byler S, Heerboth S, Lapinska K, Longacre M, Snyder N, et al. Drug resistance in cancer: an overview. Cancers. 2014;6(3):1769\u201392.","journal-title":"Cancers"},{"key":"1175_CR22","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1007\/s13738-013-0402-6","volume":"11","author":"S Pirhadi","year":"2014","unstructured":"Pirhadi S, Shiri F, Ghasemi JB. Pharmacophore elucidation and 3D-QSAR analysis of a new class of highly potent inhibitors of acid ceramidase based on maximum common substructure and field fit alignment methods. J Iran Chem Soc. 2014;11:1329\u201336.","journal-title":"J Iran Chem Soc"},{"key":"1175_CR23","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1007\/s13738-015-0669-x","volume":"12","author":"E Nazarshodeh","year":"2015","unstructured":"Nazarshodeh E, Shiri F, Ghasemi JB. 3D-QSAR and virtual screening studies in identification of new Rho kinase inhibitors with different scaffolds. J Iran Chem Soc. 2015;12:1945\u201359.","journal-title":"J Iran Chem Soc"},{"issue":"9","key":"1175_CR24","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1517\/17460441.3.9.1011","volume":"3","author":"DV Green","year":"2008","unstructured":"Green DV. Virtual screening of chemical libraries for drug discovery. Expert Opin Drug Discov. 2008;3(9):1011\u201326.","journal-title":"Expert Opin Drug Discov"},{"issue":"8","key":"1175_CR25","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1517\/17460441.3.8.841","volume":"3","author":"DE Clark","year":"2008","unstructured":"Clark DE. What has virtual screening ever done for drug discovery? Expert Opin Drug Discov. 2008;3(8):841\u201351.","journal-title":"Expert Opin Drug Discov"},{"issue":"20","key":"1175_CR26","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/S1359-6446(02)02483-2","volume":"7","author":"PD Lyne","year":"2002","unstructured":"Lyne PD. Structure-based virtual screening: an overview. Drug Discov Today. 2002;7(20):1047\u201355.","journal-title":"Drug Discov Today"},{"key":"1175_CR27","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/978-981-15-8936-2_12","volume-title":"Innovations and implementations of computer aided drug discovery strategies in rational drug design","author":"R Shukla","year":"2021","unstructured":"Shukla R, Tripathi T. Molecular dynamics simulation in drug discovery: opportunities and challenges. In: Innovations and implementations of computer aided drug discovery strategies in rational drug design. Singapore: Springer; 2021. p. 295\u2013316."},{"issue":"12","key":"1175_CR28","doi-asserted-by":"publisher","first-page":"5073","DOI":"10.1021\/acs.jmedchem.7b00901","volume":"61","author":"S Philip","year":"2017","unstructured":"Philip S, Kumarasiri M, Teo T, Yu M, Wang S. Cyclin-dependent kinase 8: a new hope in targeted cancer therapy? Miniperspect J Med Chem. 2017;61(12):5073\u201392.","journal-title":"Miniperspect J Med Chem"},{"key":"1175_CR29","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/0471721204.ch25","volume":"44","author":"E Krieger","year":"2003","unstructured":"Krieger E, Nabuurs SB, Vriend G. Homology modeling. Struct Bioinform. 2003;44:509\u201323.","journal-title":"Struct Bioinform"},{"key":"1175_CR30","first-page":"629","volume-title":"PyMOL user\u2019s guide","author":"WL DeLano","year":"2004","unstructured":"DeLano WL, Bromberg S. PyMOL user\u2019s guide. Palo Alto: DeLano Scientific LLC.; 2004. p. 629."},{"key":"1175_CR31","doi-asserted-by":"publisher","first-page":"770","DOI":"10.4018\/978-1-5225-1762-7.ch030","volume-title":"Pharmaceutical sciences: breakthroughs in research and practice","author":"JB Ghasemi","year":"2017","unstructured":"Ghasemi JB, Abdolmaleki A, Shiri F. Molecular docking challenges and limitations. In: Pharmaceutical sciences: breakthroughs in research and practice. Hershey: IGI Global; 2017. p. 770\u201394."},{"key":"1175_CR32","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/B978-0-12-822312-3.00010-2","volume-title":"Molecular docking for computer-aided drug design","author":"A Abdolmaleki","year":"2021","unstructured":"Abdolmaleki A, Shiri F, Ghasemi JB. Use of molecular docking as a decision-making tool in drug discovery. In: Molecular docking for computer-aided drug design. London: Elsevier; 2021. p. 229\u201343."},{"issue":"8","key":"1175_CR33","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1021\/ci300604z","volume":"53","author":"DR Koes","year":"2013","unstructured":"Koes DR, Baumgartner MP, Camacho CJ. Lessons learned in empirical scoring with smina from the CSAR 2011 benchmarking exercise. J Chem Inf Model. 2013;53(8):1893\u2013904.","journal-title":"J Chem Inf Model"},{"key":"1175_CR34","first-page":"455","volume":"31","author":"O Trott","year":"2009","unstructured":"Trott O, Olson A. Software news and update AutoDock Vina: improving the speed and accuracy of docking with a new scoring function. Effic Optim Multithreading. 2009;31:455\u201361.","journal-title":"Effic Optim Multithreading"},{"key":"1175_CR35","doi-asserted-by":"crossref","unstructured":"Csizmadia P. MarvinSketch and MarvinView: molecule applets for the World Wide Web; 1999.","DOI":"10.3390\/ecsoc-3-01775"},{"issue":"1","key":"1175_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1758-2946-3-33","volume":"3","author":"NM O'Boyle","year":"2011","unstructured":"O\u2019Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR. Open Babel: an open chemical toolbox. J Cheminform. 2011;3(1):1\u201314.","journal-title":"J Cheminform"},{"issue":"2","key":"1175_CR37","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1006\/jmbi.1999.3371","volume":"295","author":"H Gohlke","year":"2000","unstructured":"Gohlke H, Hendlich M, Klebe G. Knowledge-based scoring function to predict protein-ligand interactions. J Mol Biol. 2000;295(2):337\u201356.","journal-title":"J Mol Biol"},{"key":"1175_CR38","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/978-3-030-05282-9_2","volume-title":"Structural bioinformatics: applications in preclinical drug discovery process","author":"C Choudhury","year":"2019","unstructured":"Choudhury C, Narahari SG. Pharmacophore modelling and screening: concepts, recent developments and applications in rational drug design. In: Structural bioinformatics: applications in preclinical drug discovery process. Berlin: Springer; 2019. p. 25\u201353."},{"issue":"9","key":"1175_CR39","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.2174\/1568026611313090006","volume":"13","author":"S Pirhadi","year":"2013","unstructured":"Pirhadi S, Shiri F, Ghasemi JB. Methods and applications of structure based pharmacophores in drug discovery. Curr Top Med Chem. 2013;13(9):1036\u201347.","journal-title":"Curr Top Med Chem"},{"issue":"5","key":"1175_CR40","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1021\/ci0500177","volume":"45","author":"A Bender","year":"2005","unstructured":"Bender A, Glen RC. A discussion of measures of enrichment in virtual screening: comparing the information content of descriptors with increasing levels of sophistication. J Chem Inf Model. 2005;45(5):1369\u201375.","journal-title":"J Chem Inf Model"},{"key":"1175_CR41","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1","author":"MJ Abraham","year":"2015","unstructured":"Abraham MJ, Murtola T, Schulz R, P\u00e1ll S, Smith JC, Hess B, et al. GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. 2015;1:19\u201325.","journal-title":"SoftwareX"},{"issue":"3","key":"1175_CR42","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1002\/prot.21123","volume":"65","author":"V Hornak","year":"2006","unstructured":"Hornak V, Abel R, Okur A, Strockbine B, Roitberg A, Simmerling C. Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins Struct Funct Bioinform. 2006;65(3):712\u201325.","journal-title":"Proteins Struct Funct Bioinform"},{"key":"1175_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.softx.2019.100241","volume":"10","author":"A Bernardi","year":"2019","unstructured":"Bernardi A, Faller R, Reith D, Kirschner KN. ACPYPE update for nonuniform 1\u20134 scale factors: conversion of the GLYCAM06 force field from AMBER to GROMACS. SoftwareX. 2019;10: 100241.","journal-title":"SoftwareX"},{"issue":"2","key":"1175_CR44","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML. Comparison of simple potential functions for simulating liquid water. J Chem Phys. 1983;79(2):926\u201335.","journal-title":"J Chem Phys"},{"issue":"3","key":"1175_CR45","doi-asserted-by":"publisher","first-page":"R55","DOI":"10.1016\/S0969-2126(99)80033-1","volume":"7","author":"T Darden","year":"1999","unstructured":"Darden T, Perera L, Li L, Pedersen L. New tricks for modelers from the crystallography toolkit: the particle mesh Ewald algorithm and its use in nucleic acid simulations. Structure. 1999;7(3):R55\u201360.","journal-title":"Structure"},{"issue":"1","key":"1175_CR46","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/0021-9991(83)90014-1","volume":"52","author":"HC Andersen","year":"1983","unstructured":"Andersen HC. Rattle: a \u201cvelocity\u201d version of the shake algorithm for molecular dynamics calculations. J Comput Phys. 1983;52(1):24\u201334.","journal-title":"J Comput Phys"},{"key":"1175_CR47","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00249-004-0448-6","volume":"34","author":"C Oostenbrink","year":"2005","unstructured":"Oostenbrink C, Soares TA, Van Der Vegt NF, Van Gunsteren WF. Validation of the 53A6 GROMOS force field. Eur Biophys J. 2005;34:273\u201384.","journal-title":"Eur Biophys J"},{"issue":"9\u201310","key":"1175_CR48","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.drudis.2011.02.011","volume":"16","author":"P Ripphausen","year":"2011","unstructured":"Ripphausen P, Nisius B, Bajorath J. State-of-the-art in ligand-based virtual screening. Drug Discov Today. 2011;16(9\u201310):372\u20136.","journal-title":"Drug Discov Today"},{"issue":"W1","key":"1175_CR49","doi-asserted-by":"publisher","first-page":"W442","DOI":"10.1093\/nar\/gkw287","volume":"44","author":"J Sunseri","year":"2016","unstructured":"Sunseri J, Koes DR. Pharmit: interactive exploration of chemical space. Nucleic Acids Res. 2016;44(W1):W442\u20138.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"1175_CR50","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.drudis.2019.03.015","volume":"24","author":"LL Ferreira","year":"2019","unstructured":"Ferreira LL, Andricopulo AD. ADMET modeling approaches in drug discovery. Drug Discov Today. 2019;24(5):1157\u201365.","journal-title":"Drug Discov Today"},{"key":"1175_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.envpol.2021.118137","volume":"291","author":"X Wang","year":"2021","unstructured":"Wang X, Wang X, Zhu Y, Chen X. ADME\/T-based strategies for paraquat detoxification: transporters and enzymes. Environ Pollut. 2021;291: 118137.","journal-title":"Environ Pollut"},{"issue":"1","key":"1175_CR52","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7(1):42717.","journal-title":"Sci Rep"},{"issue":"2","key":"1175_CR53","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1021\/ci500588j","volume":"55","author":"T Sander","year":"2015","unstructured":"Sander T, Freyss J, von Korff M, Rufener C. DataWarrior: an open-source program for chemistry aware data visualization and analysis. J Chem Inf Model. 2015;55(2):460\u201373.","journal-title":"J Chem Inf Model"},{"issue":"W1","key":"1175_CR54","doi-asserted-by":"publisher","first-page":"W257","DOI":"10.1093\/nar\/gky318","volume":"46","author":"P Banerjee","year":"2018","unstructured":"Banerjee P, Eckert AO, Schrey AK, Preissner R. ProTox-II: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Res. 2018;46(W1):W257\u201363.","journal-title":"Nucleic Acids Res"},{"key":"1175_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112459","volume":"146","author":"TE Lin","year":"2022","unstructured":"Lin TE, Yang C-R, Chou C-H, Hsu J-Y, Chao M-W, Sung T-Y, et al. Discovery of a novel cyclin-dependent kinase 8 inhibitor with an oxindole core for anti-inflammatory treatment. Biomed Pharmacother. 2022;146: 112459.","journal-title":"Biomed Pharmacother"}],"container-title":["BMC Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-024-01175-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13065-024-01175-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-024-01175-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T19:01:36Z","timestamp":1713034896000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcchem.biomedcentral.com\/articles\/10.1186\/s13065-024-01175-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,13]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1175"],"URL":"https:\/\/doi.org\/10.1186\/s13065-024-01175-6","relation":{},"ISSN":["2661-801X"],"issn-type":[{"value":"2661-801X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,13]]},"assertion":[{"value":"13 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"73"}}